Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 2,615 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sleep-Wake Disorders Clear all

Conditions: Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: Dr. Erica Thaler; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Low Back Pain (CLBP), Insomnia
Interventions: Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation, CBTi + Pain Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pain, Back, Pain, Acute, Sleep Disorder, Sleep Disorders, Circadian Rhythm, Sleep, Sleep Deprivation, Insomnia
Interventions: Drug- free, non-invasive patch (FREEDOM or REM Patch) with haptic vibrotactile trigger technology (VTT) Other Names:, Sham Patch without haptic vibrotactile trigger technology (VTT); Device
Lead sponsor: SuperPatch Limited LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tyrone, Georgia

Conditions: Obstructive Sleep Apnea
Interventions: Web-based Access to CPAP Data, Web-based Access to CPAP Data with Financial Incentive; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Wynnewood, Pennsylvania

Conditions: Central Apnea, Heart Failure
Interventions: Acetazolamide, Buspirone; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease
Interventions: CPET; Diagnostic Test
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma

Conditions: Insomnia
Interventions: NBI-34060; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 4
States / cities: Atlanta, Georgia • New York, New York • Cincinnati, Ohio

Conditions: Obstructive Sleep Apnea
Interventions: Mask A (Oran Park Mask) then Mask B (Evora Mask), Mask B (Evora Mask) then Mask A (Oran Park Mask); Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: San Diego, California • St Louis, Missouri

Conditions: Insomnia Disorder
Interventions: Daridorexant, Non-orexin receptor antagonist insomnia medication, No insomnia medication; Drug · Other
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 2,095 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Sleep, Wearable Technology, Cortisol, Healthy Participants, Cognitive Abilities
Interventions: PeptiSleep, Micro-crystalline cellulose; Dietary Supplement
Lead sponsor: Nuritas Ltd; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Sleep Apnea Syndromes
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,685 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea
Interventions: Zansors® sleep screening device; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea
Interventions: Fitbit, OSA questionnaire, Polysomnography; Device · Other · Diagnostic Test
Lead sponsor: Vidya Raman; Other
Eligibility: 3 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Sleep Deprivation, Sleep Restriction, Acoustic Stimulation, Performance, Alertness
Interventions: Philips SmartSleep Acoustic Stimulation Device, Sham (no Acoustic Stimulation); Device
Lead sponsor: Walter Reed Army Institute of Research (WRAIR); Federal
Eligibility: 18 Years to 39 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Sleep Disorder
Interventions: ABT-652, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 5
States / cities: Phoenix, Arizona • Glendale, California • San Diego, California + 2 more

Conditions: Narcolepsy
Interventions: JZP441, Matching Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Atlanta, Georgia • Cincinnati, Ohio • Columbia, South Carolina + 1 more

Conditions: Obstructive Sleep Apnea, Obstructive Sleep Apnea of Adult
Interventions: No HGNS therapy (HGNS-off); Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Transient Insomnia
Interventions: Gabapentin, Placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 773 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 10
States / cities: San Diego, California • Ocala, Florida • Atlanta, Georgia + 6 more

Conditions: Sleep Disturbance
Interventions: Calm; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Older Adults (65 Years and Older)
Interventions: Cognitive-behavioral therapy for insomnia, Sleep hygiene education; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Insomnia
Interventions: Ramelteon, Usual Care; Drug · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: CNS
Interventions: E2006, Placebo comparator; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Culver City, California • Glendale, California

Conditions: Insomnia
Interventions: Internet-based Self-help Insomnia Intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Conscious Sedation, Bronchoscopy
Interventions: Not listed
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Diagnostic Validation of Drug-Induced Sleep Endoscopy (DISE)

Resilience Enhancement Following Sleep Treatment

Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches

Promoting Continuous Positive Airway Pressure (CPAP) Adherence

Buspirone as a Potential Treatment for Recurrent Central Apnea

Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome

An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

Oran Park Mask External Clinical Study (3) Marketing Claims Study

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Effects of PeptiSleep on Sleep Quality in Healthy Adults

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

Validation of Sleep Apnea Screening Device

Comparing Fitbit® Quality of Measured Sleep to Sleep Measured by Polysomnography in the Sleep Lab

Acoustic Stimulation During Restricted Sleep After Sleep Deprivation

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance

Feasibility of a Mobile App on Sleep

CBT-I in Older African American Adults

Ramelteon for Complex Insomnia in Veterans With PTSD

2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects

Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care

Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study